SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 369 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,749 | -99.6% | 13,511 | +126.5% | 0.06% | +369.2% |
Q1 2021 | $444,000 | -59.2% | 5,964 | -6.5% | 0.01% | -62.9% |
Q4 2020 | $1,087,000 | +25.2% | 6,377 | +3.1% | 0.04% | +9.4% |
Q3 2020 | $868,000 | -30.4% | 6,183 | -20.5% | 0.03% | -33.3% |
Q2 2020 | $1,247,000 | +74.6% | 7,779 | +6.5% | 0.05% | +45.5% |
Q1 2020 | $714,000 | -27.0% | 7,301 | -3.6% | 0.03% | +3.1% |
Q4 2019 | $978,000 | +54.5% | 7,576 | -9.9% | 0.03% | +52.4% |
Q3 2019 | $633,000 | -51.5% | 8,410 | -2.1% | 0.02% | -51.2% |
Q2 2019 | $1,305,000 | +9.9% | 8,590 | -13.7% | 0.04% | +13.2% |
Q1 2019 | $1,187,000 | -76.2% | 9,959 | -78.2% | 0.04% | -78.4% |
Q4 2018 | $4,994,000 | -30.9% | 45,763 | +2.3% | 0.18% | -17.0% |
Q3 2018 | $7,222,000 | +8.7% | 44,714 | -11.0% | 0.21% | +7.6% |
Q2 2018 | $6,641,000 | +10.2% | 50,245 | -38.2% | 0.20% | -4.4% |
Q1 2018 | $6,026,000 | -5.9% | 81,330 | -29.3% | 0.21% | -5.5% |
Q4 2017 | $6,401,000 | +14.9% | 115,042 | -6.3% | 0.22% | +14.7% |
Q3 2017 | $5,569,000 | – | 122,790 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |